Literature DB >> 15124832

Respiratory outcome in school-aged, very-low-birth-weight children in the surfactant era.

P Korhonen1, J Laitinen, E Hyödynmaa, O Tammela.   

Abstract

AIM: To assess respiratory outcome and its predictors during the surfactant era in very-low-birth-weight (VLBW, birth weight <1500g) schoolchildren with and without bronchopulmonary dysplasia (BPD).
METHODS: At 7-8 years of age, 34 VLBW children with BPD diagnosed at a postnatal age of 28 d underwent flow-volume spirometry, metacholine challenge, bronchodilatation test, whole body plethysmography and diffusion capacity measurement. Fourteen of them had not recovered from BPD by a corrected gestational age of 36 wk (sBPD subgroup). The age- and sex-matched control groups comprised 34 VLBW cases without BPD and 34 term children.
RESULTS: Current respiratory symptoms in contact with cold air and/or upon exercise were reported in one-third of the VLBW children. Only half of the symptomatic VLBW cases without BPD had inhaled medications. Compared with term controls, the BPD cases had lower forced expiratory volume in 1 s (FEV1), higher ratio of residual volume to total lung capacity and higher airway resistance. Lower FEV1 and specific conductance were found in the sBPD subgroup compared to both control groups. Additionally, their vital capacity was lower than in term controls. A higher rate of bronchial hyper-reactivity and lower diffusion capacity of the lungs were detected in VLBW as against term cases. Low birth weight, long duration of oxygen therapy, low socio-economic status and exposure to animal dander emerged as predictors of poorer respiratory outcome.
CONCLUSION: In the surfactant era, birth weight, neonatal respiratory morbidity, as well as later environmental factors appear to affect the respiratory outcome of VLBW children. However, careful pulmonary follow-up of all VLBW children seems to be indicated regardless of the severity of neonatal respiratory problems.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15124832     DOI: 10.1080/08035250410023593

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  21 in total

1.  Chorioamnionitis stimulates angiogenesis in saccular stage fetal lungs via CC chemokines.

Authors:  J Davin Miller; John T Benjamin; David R Kelly; David B Frank; Lawrence S Prince
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-02-19       Impact factor: 5.464

Review 2.  Understanding the Short- and Long-Term Respiratory Outcomes of Prematurity and Bronchopulmonary Dysplasia.

Authors:  Jessica Y Islam; Roberta L Keller; Judy L Aschner; Tina V Hartert; Paul E Moore
Journal:  Am J Respir Crit Care Med       Date:  2015-07-15       Impact factor: 21.405

3.  Asthma is associated with preterm birth but not with small for gestational age status among a population-based cohort of Medicaid-enrolled children <10 years of age.

Authors:  Bradford D Gessner; Marc-Andre R Chimonas
Journal:  Thorax       Date:  2006-10-13       Impact factor: 9.139

Review 4.  Assessment of inhibited alveolar-capillary membrane structural development and function in bronchopulmonary dysplasia.

Authors:  Shawn K Ahlfeld; Simon J Conway
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2014-03-06

Review 5.  Confounding biases in studies on early- versus late-caffeine in preterm infants: a systematic review.

Authors:  Sandra Nylander Vujovic; Chiara Nava; Minna Johansson; Matteo Bruschettini
Journal:  Pediatr Res       Date:  2020-01-13       Impact factor: 3.756

6.  Lung function and respiratory symptoms at 11 years in children born extremely preterm: the EPICure study.

Authors:  Joseph Fawke; Sooky Lum; Jane Kirkby; Enid Hennessy; Neil Marlow; Victoria Rowell; Sue Thomas; Janet Stocks
Journal:  Am J Respir Crit Care Med       Date:  2010-04-08       Impact factor: 21.405

7.  Aerobic fitness and physical activity levels of children born prematurely following randomization to postnatal dexamethasone.

Authors:  Patricia A Nixon; Lisa K Washburn; Lanay M Mudd; Heather H Webb; T Michael O'Shea
Journal:  J Pediatr       Date:  2010-08-21       Impact factor: 4.406

8.  Follow-up study of a randomized controlled trial of postnatal dexamethasone therapy in very low birth weight infants: effects on pulmonary outcomes at age 8 to 11 years.

Authors:  Patricia A Nixon; Lisa K Washburn; Michael S Schechter; T Michael O'Shea
Journal:  J Pediatr       Date:  2007-04       Impact factor: 4.406

Review 9.  The Natural History of Bronchopulmonary Dysplasia: The Case for Primary Prevention.

Authors:  Cindy T McEvoy; Judy L Aschner
Journal:  Clin Perinatol       Date:  2015-10-01       Impact factor: 3.430

10.  One-year respiratory outcomes of preterm infants enrolled in the Nitric Oxide (to prevent) Chronic Lung Disease trial.

Authors:  Anna Maria Hibbs; Michele C Walsh; Richard J Martin; William E Truog; Scott A Lorch; Evaline Alessandrini; Avital Cnaan; Lisa Palermo; Sandra R Wadlinger; Christine E Coburn; Philip L Ballard; Roberta A Ballard
Journal:  J Pediatr       Date:  2008-06-04       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.